Matches in Nanopublications for { ?s ?p ?o <http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#assertion>. }
Showing items 1 to 16 of
16
with 100 items per page.
- association type Statement assertion.
- association label "ABSTRAL® is indicated for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving, and who are tolerant to, around-the-clock opioid therapy for their underlying persistent cancer pain." assertion.
- cohort label "cancer patients 18 years of age and older who are already receiving, and who are tolerant to, around-the-clock opioid therapy for their underlying persistent cancer pain" assertion.
- association subject CHEBI:119915 assertion.
- association predicate treats assertion.
- association object MONDO:0021668 assertion.
- association has_population_context cohort assertion.
- association relation TreatmentIndication assertion.
- cohort category Cohort assertion.
- MONDO:0021668 category Disease assertion.
- CHEBI:119915 category Drug assertion.
- association association_type ChemicalToDiseaseOrPhenotypicFeatureAssociation assertion.
- cohort requiredMinAge "18" assertion.
- association publications drugInfo.cfm?setid=e60f00e9-2cf4-4c20-b570-1c2ea426c8c7 assertion.
- association provided_by "NeuroDKG" assertion.
- cohort has_phenotype MONDO:0005070 assertion.